There’s new hope for patients with mesothelioma lung cancer from asbestos exposure, as the U.S. Food and Drug Administration (FDA) just recently approved a new drug for use in the treatment of this fast-moving disease.
Manufactured by Merck, Keytruda (pembrolizumab) is an immunotherapy drug that’s now approved for treating mesothelioma and other advanced cases of non-small cell lung cancer or NSCLC. This new immunotherapy medication for mesothelioma patients obstructs special PD-1 and PD-L1 proteins called cellular pathways which are present on cancer cells. By blocking these proteins, this drug allows the body’s immune system to fight the cancer more effectively.
Keytruda will not be effective for all mesothelioma lung cancer patients. Between 20% and 40% of mesothelioma tumors have the PD-1/PD-L1 proteins that are targeted by this immunotherapy drug.
But for those mesothelioma patients who do have this specific type of protein, this medication offers new hope as it represents “a significant improvement in safety or effectiveness in the treatment of a serious disease” — a fact that actually enabled Keytruda to obtain expedited FDA approval.
In addition to approving Keytrude for mesothelioma cancer patients, the FDA also approved the usage of a one-of-a-kind diagnostic test that is designed to identify patients who have tumors that contain the specific proteins that are targeted by this immunotherapy medication.
In addition to treating mesothelioma in asbestos exposure victims, Keytruda is also used to treat patients with melanoma and other forms of lung cancer.
Additional Help for Patients with Mesothelioma from Asbestos Exposure
In addition to this new immunotherapy drug for mesothelioma and other cancers, there is also new hope in the form of mesothelioma clinical trials, which provide patients with access to the newest, groundbreaking therapies and medications.
Asbestos exposure can not only lead to mesothelioma, but also other diseases such as asbestosis, chronic obstructive pulmonary disease (COPD), pleural thickening, pleural effusion and pleurisy. Individuals who’ve suffered asbestos exposure may be eligible for special programs, financial benefits, and even money from asbestos and mesothelioma trust funds. Some may also wish to pursue a mesothelioma claim in the form of an asbestos lawsuit against the company, organization, government agency or others who are responsible and liable for their asbestos exposure.
If you or a loved one received a mesothelioma diagnosis or developed another asbestos exposure disease, you need a qualified mesothelioma attorney working hard on your side. But you must take action immediately because there is a limit on how long you have to file an asbestos claim or mesothelioma lawsuit.
The Mesowatch asbestos law team connects you with experienced team of asbestos and mesothelioma lawyers and provides a free confidential case evaluation. More information can be reviewed at https://mesowatch.com/mesothelioma-lawyers/ Arrange your free case consultation today. Call (800) 956-9876.